Deconstruction of the Frontage Building starting

14 Feb 2025, 9 a.m.

A photograph showing scaffolding and sheeting around the frontage building

We are pleased to announce that deconstruction of the Frontage Building will start on Monday 17 February.

This is a major step forward and means we are nearer to realising our ambition to provide a new home for cancer services, as well as more space for our school, imaging, critical care and theatre services and an amazing new entrance for the whole hospital.

The deconstruction process will be managed carefully by our contractor Sisk and the works will be overseen by the GOSH CCC team.

Information for visitors to GOSH

While it is exciting that we are developing this amazing new facility, we know that this activity may make things feel different for visitors to the hospital.

From your ward window you may be able to see the deconstruction site and works on site. There may be noise at times, but please note there are quiet periods during the day when the sound limits are lower.

These times are:

  • 7am - 8am
  • 12pm - 1pm
  • 5pm - 6pm.

There are maximum limits at all times and no work takes place after 6pm Monday-Friday, or after 1pm on Saturdays.

Please talk to your ward team if the work is disturbing you or you have any concerns.

Thank you for bearing with us as we develop the new building. Contact us if you have any questions or concerns:
Email: ccc@gosh.nhs.uk

Find out more about the Children's Cancer Centre, including how we are managing the deconstruction process.

New research analyses key immune cell

A new study led by researchers at University College London Great Ormond Street Institute of Child Health has found that women have a higher proportion of key immune cells between puberty and menopause.

Say thank you to a nurse that's helped you

The DAISY Award is an international recognition programme that honours and celebrates the incredible work of nurses and midwives. You can nominate a registered nurse for three different categories - here's how.

First patient treated with groundbreaking gene therapy trial

A baby boy born with a rare condition has become the first in the world to be treated with a new, potentially lifechanging, investigational gene therapy on a clinical trial at Great Ormond Street Hospital (GOSH).

Professor Darren Hargrave appointed NIHR Senior Investigator

We’re delighted to announce that Professor Darren Hargrave has been named as a NIHR Senior Investigator in this year’s prestigious awards list.